Sfoglia per AUTORE
DE FRANCIA S
Collezione ASL Città di Torino

  

Items : 22

Central Serous Chorioretinopathy in Endometriosis Treatment with Progestogen: A Metabolic Understanding. in Life (Basel, Switzerland) / Life (Basel). 2025 Jan 22;15(2):144. doi: 10.3390/life15020144.
2025
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

De Francia S; Mengozzi G; Liuzzi S; Puccinelli MP; Turco D; Caudana M; Mula J; Allegra S; Chiara F;

The Strange Case of Orotic Acid: The Different Expression of Pyrimidines Biosynthesis in Healthy Males and Females. in Journal of personalized medicine / J Pers Med. 2023 Sep 28;13(10):1443. doi: 10.3390/jpm13101443.
2023
ASL Città di Torino
AOU Città della Salute di Torino

De Francia S; Mengozzi G; Abbadessa G; Puccinelli MP; Mula J; Allegra S; Chiara F;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
AOU San Luigi di Orbassano

Antonucci M; D'Avolio A; Manca A; Avataneo V; Cusato J; Allegra S; De Francia S; De Nicolò A;

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;

Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Jan;28(1):17-22. doi: 10.1097/FPC.0000000000000315.
2018
ASL Città di Torino

Allegra S; Cusato J; De Francia S; Longo F; Pirro E; Massano D; Piga A; D'Avolio A;

Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A; Allegra S; Massano D; De Francia S; Longo F; Piccione F; Pirro E; Cusato J; D'Avolio A; Piga A;

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;

Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox AUC efficacy cutoff and role of pharmacogenetics. in European journal of clinical pharmacology / Eur J Clin Pharmacol. 2016 Sep;72(9):1155-7. doi: 10.1007/s00228-016-2070-9. Epub 2016 May 18.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Massano D; Piga A; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2016 Nov;68(11):1417-1421. doi: 10.1111/jphp.12638. Epub 2016 Sep 27.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Massano D; Pirro E; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Pirro E; Arduino A; Cusato J; Massano D; Longo F; De Francia S; Allegra S; D'Avolio A;

Role of pharmacogenetics on deferasirox AUC and efficacy. in Pharmacogenomics / Pharmacogenomics. 2016 Apr;17(6):561-72. doi: 10.2217/pgs-2015-0001. Epub 2016 Apr 4.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; De Francia S; Allegra S; Cusato J;

Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness. in The pharmacogenomics journal / Pharmacogenomics J. 2015 Jun;15(3):263-71. doi: 10.1038/tpj.2014.65. Epub 2014 Oct 28.
2015
ASL Città di Torino

Cusato J; Allegra S; Massano D; De Francia S; Piga A; D'Avolio A;

Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2013 Jun;23(6):293-300. doi: 10.1097/FPC.0b013e3283606cb2.
2013
ASL Città di Torino

D'Avolio A; De Francia S; Basile V; Cusato J; De Martino F; Pirro E; Piccione F; Ardito A; Zaggia B; Volante M; Di Perri G; Terzolo M;

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Feb 5;59:109-16. doi: 10.1016/j.jpba.2011.10.003. Epub 2011 Oct 14.
2012
ASL Città di Torino

D'Avolio A; Simiele M; De Francia S; Ariaudo A; Baietto L; Cusato J; Fava C; Saglio G; Di Carlo F; Di Perri G;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte